Steven M. Rowe, M.D., MSPH, has been named director of the Gregory Fleming James Cystic Fibrosis Research Center in the UAB School of Medicine, effective Aug. 1.
As a young girl in Afghanistan, Fazila Aseem watched her grandmother struggle to complete daily tasks independently due to vision loss. This summer, Aseem will work with researchers in the Department of Ophthalmology to continue her interest in aging and vision research.
UAB is set to open a mental health clinic July 20 that will improve access to care for those who identify as LGBTQ.
Monika M. Safford, M.D., helped shape the new Web tool for the National Diabetes Education Program, “Promoting Medication Adherence in Diabetes.”
UAB’s ongoing research for countermeasures to bromine or chlorine exposure — from either industrial spills or chemical attack — gets a boost with a new NIH grant.
UAB’s Candace Floyd is set to take a top leadership post with the National Neurotrauma Society.
Haydeh Payami, Ph.D., a leading geneticist recruited to the UAB-Hudson Alpha Center for Genomic Medicine and UAB Personalized Medicine Institute, is exploring the protective power of coffee and nicotine — and the mysteries of the microbiome — in Parkinson’s disease.
Rates of vision impairment are high among seniors living in subsidized housing, suggesting an increased need for widespread vision screening.
The mimicry of bone cells by multiple myeloma is driven by overexpression of Runx2, the master regulator of bone formation.
UAB Hospital is the only Disease-Specific Certified program in Alabama and has had no observations or findings by The Joint Commission since joining the certification process.